Ezra Cohen was named chief medical officer of oncology at Tempus, an artificial intelligence and precision medicine company.
Diane Simeone, director of Moores Cancer Center at UC San Diego Health, has expanded her leadership team.
Ezra Cohen named chief medical officer of oncology at Tempus
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
Personalis Inc. announced the commencement of commercialization efforts by Tempus for NeXT Personal, Personalis’ ultra-sensitive, whole genome-based liquid biopsy assay for detection of minimal residual disease and recurrence in cancer.
Alligator Bioscience has announced the initiation of a phase I clinical study (NCT06205849) to evaluate the safety and efficacy of mitazalimab (CD40 mAb agonist) injected intratumorally at the time of surgical irreversible electroporation (IRE) in patients with locally advanced pancreatic cancer.
Tempus has sent de-identified tumor profiles with limited associated clinical information from more than 3,000 cancer diagnoses to the NCI.
Diane M. Simeone will become director of Moores Cancer Center at UC San Diego Health effective April 1.
Seanne Falconer was named administrative director at Tulane Cancer Center at Tulane University School of Medicine.
